Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Comparison of Anticoagulation with Left Atrial Appendage Closure after AF Ablation
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation (OPTION)
Sponsor:Boston Scientific Corporation
Enrolling:Male and Female Patients
Minimum Age:18 years old
IRB Number:AAAS7799
U.S. Government ID:NCT03795298
Contact: Cathy Moore: 212-342-3490 / cjm2285@cumc.columbia.edu
Additional Study Information:

This study is a prospective, randomized, multi-center, global investigation to determine if left atrial appendage closure with the WATCHMAN FLX Device is a reasonable alternative to oral anticoagulation in patients after AF ablation.

Do You Qualify?
Do you have atrial fibrillation?YesNo
Do you have a mechanical heart valve implant?YesNo
Have you had an atrial septal repair or a left atrial appendage closure?YesNo
Submit
Cancel
Investigator
Amardeep Saluja, MD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Cathy Moore
Email: cjm2285@cumc.columbia.edu
Phone: 212-342-3490